278 related articles for article (PubMed ID: 35248997)
1. A comparison of machine learning methods for predicting recurrence and death after curative-intent radiotherapy for non-small cell lung cancer: Development and validation of multivariable clinical prediction models.
Hindocha S; Charlton TG; Linton-Reid K; Hunter B; Chan C; Ahmed M; Robinson EJ; Orton M; Ahmad S; McDonald F; Locke I; Power D; Blackledge M; Lee RW; Aboagye EO
EBioMedicine; 2022 Mar; 77():103911. PubMed ID: 35248997
[TBL] [Abstract][Full Text] [Related]
2. Gross tumour volume radiomics for prognostication of recurrence & death following radical radiotherapy for NSCLC.
Hindocha S; Charlton TG; Linton-Reid K; Hunter B; Chan C; Ahmed M; Greenlay EJ; Orton M; Bunce C; Lunn J; Doran SJ; Ahmad S; McDonald F; Locke I; Power D; Blackledge M; Lee RW; Aboagye EO
NPJ Precis Oncol; 2022 Oct; 6(1):77. PubMed ID: 36302938
[TBL] [Abstract][Full Text] [Related]
3. Predicting the Risk of Disease Recurrence and Death Following Curative-intent Radiotherapy for Non-small Cell Lung Cancer: The Development and Validation of Two Scoring Systems From a Large Multicentre UK Cohort.
Evison M; Barrett E; Cheng A; Mulla A; Walls G; Johnston D; McAleese J; Moore K; Hicks J; Blyth K; Denholm M; Magee L; Gilligan D; Silverman S; Hiley C; Qureshi M; Clinch H; Hatton M; Philipps L; Brown S; O'Brien M; McDonald F; Faivre-Finn C
Clin Oncol (R Coll Radiol); 2021 Mar; 33(3):145-154. PubMed ID: 32978027
[TBL] [Abstract][Full Text] [Related]
4. Development and Validation of a Machine Learning Model to Explore Tyrosine Kinase Inhibitor Response in Patients With Stage IV EGFR Variant-Positive Non-Small Cell Lung Cancer.
Song J; Wang L; Ng NN; Zhao M; Shi J; Wu N; Li W; Liu Z; Yeom KW; Tian J
JAMA Netw Open; 2020 Dec; 3(12):e2030442. PubMed ID: 33331920
[TBL] [Abstract][Full Text] [Related]
5. Prediction of pathologic stage in non-small cell lung cancer using machine learning algorithm based on CT image feature analysis.
Yu L; Tao G; Zhu L; Wang G; Li Z; Ye J; Chen Q
BMC Cancer; 2019 May; 19(1):464. PubMed ID: 31101024
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy (excluding checkpoint inhibitors) for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent.
Zhu J; Li R; Tiselius E; Roudi R; Teghararian O; Suo C; Song H
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011300. PubMed ID: 29247502
[TBL] [Abstract][Full Text] [Related]
7. CT imaging features associated with recurrence in non-small cell lung cancer patients after stereotactic body radiotherapy.
Li Q; Kim J; Balagurunathan Y; Qi J; Liu Y; Latifi K; Moros EG; Schabath MB; Ye Z; Gillies RJ; Dilling TJ
Radiat Oncol; 2017 Sep; 12(1):158. PubMed ID: 28946909
[TBL] [Abstract][Full Text] [Related]
8. Population-based analysis of curative therapies in stage II non-small cell lung cancer: the role of radiotherapy in medically inoperable patients.
Moore S; Leung B; Wu J; Ho C
Radiat Oncol; 2020 Jan; 15(1):23. PubMed ID: 32000829
[TBL] [Abstract][Full Text] [Related]
9. Machine Learning-Assisted Recurrence Prediction for Patients With Early-Stage Non-Small-Cell Lung Cancer.
Janik A; Torrente M; Costabello L; Calvo V; Walsh B; Camps C; Mohamed SK; Ortega AL; Nováček V; Massutí B; Minervini P; Campelo MRG; Del Barco E; Bosch-Barrera J; Menasalvas E; Timilsina M; Provencio M
JCO Clin Cancer Inform; 2023 Jul; 7():e2200062. PubMed ID: 37428988
[TBL] [Abstract][Full Text] [Related]
10. Combining handcrafted features with latent variables in machine learning for prediction of radiation-induced lung damage.
Cui S; Luo Y; Tseng HH; Ten Haken RK; El Naqa I
Med Phys; 2019 May; 46(5):2497-2511. PubMed ID: 30891794
[TBL] [Abstract][Full Text] [Related]
11. Machine-Learning and Stochastic Tumor Growth Models for Predicting Outcomes in Patients With Advanced Non-Small-Cell Lung Cancer.
Siah KW; Khozin S; Wong CH; Lo AW
JCO Clin Cancer Inform; 2019 Sep; 3():1-11. PubMed ID: 31539267
[TBL] [Abstract][Full Text] [Related]
12. Survival prediction for stage I-IIIA non-small cell lung cancer using deep learning.
Zheng S; Guo J; Langendijk JA; Both S; Veldhuis RNJ; Oudkerk M; van Ooijen PMA; Wijsman R; Sijtsema NM
Radiother Oncol; 2023 Mar; 180():109483. PubMed ID: 36690302
[TBL] [Abstract][Full Text] [Related]
13. Nomograms for Predicting Overall and Recurrence-free Survival From Pathologic Stage IA and IB Lung Cancer After Lobectomy.
Merritt RE; Abdel-Rasoul M; Fitzgerald M; D'Souza DM; Kneuertz PJ
Clin Lung Cancer; 2021 Jul; 22(4):e574-e583. PubMed ID: 33234491
[TBL] [Abstract][Full Text] [Related]
14. Radiomics for prediction of radiation-induced lung injury and oncologic outcome after robotic stereotactic body radiotherapy of lung cancer: results from two independent institutions.
Bousabarah K; Blanck O; Temming S; Wilhelm ML; Hoevels M; Baus WW; Ruess D; Visser-Vandewalle V; Ruge MI; Treuer H; Kocher M
Radiat Oncol; 2021 Apr; 16(1):74. PubMed ID: 33863358
[TBL] [Abstract][Full Text] [Related]
15. CT derived radiomic score for predicting the added benefit of adjuvant chemotherapy following surgery in stage I, II resectable non-small cell lung cancer: a retrospective multicohort study for outcome prediction.
Vaidya P; Bera K; Gupta A; Wang X; Corredor G; Fu P; Beig N; Prasanna P; Patil PD; Velu PD; Rajiah P; Gilkeson R; Feldman MD; Choi H; Velcheti V; Madabhushi A
Lancet Digit Health; 2020 Mar; 2(3):e116-e128. PubMed ID: 33334576
[TBL] [Abstract][Full Text] [Related]
16. Imaging features from pretreatment CT scans are associated with clinical outcomes in nonsmall-cell lung cancer patients treated with stereotactic body radiotherapy.
Li Q; Kim J; Balagurunathan Y; Liu Y; Latifi K; Stringfield O; Garcia A; Moros EG; Dilling TJ; Schabath MB; Ye Z; Gillies RJ
Med Phys; 2017 Aug; 44(8):4341-4349. PubMed ID: 28464316
[TBL] [Abstract][Full Text] [Related]
17. Predicting 5-Year Progression and Survival Outcomes for Early Stage Non-small Cell Lung Cancer Treated with Stereotactic Ablative Radiation Therapy: Development and Validation of Robust Prognostic Nomograms.
Kang J; Ning MS; Feng H; Li H; Bahig H; Brooks ED; Welsh JW; Ye R; Miao H; Chang JY
Int J Radiat Oncol Biol Phys; 2020 Jan; 106(1):90-99. PubMed ID: 31586665
[TBL] [Abstract][Full Text] [Related]
18. Development and Validation of a Deep Learning Model for Non-Small Cell Lung Cancer Survival.
She Y; Jin Z; Wu J; Deng J; Zhang L; Su H; Jiang G; Liu H; Xie D; Cao N; Ren Y; Chen C
JAMA Netw Open; 2020 Jun; 3(6):e205842. PubMed ID: 32492161
[TBL] [Abstract][Full Text] [Related]
19. Comparison and Fusion of Machine Learning Algorithms for Prospective Validation of PET/CT Radiomic Features Prognostic Value in Stage II-III Non-Small Cell Lung Cancer.
Sepehri S; Tankyevych O; Upadhaya T; Visvikis D; Hatt M; Cheze Le Rest C
Diagnostics (Basel); 2021 Apr; 11(4):. PubMed ID: 33918681
[TBL] [Abstract][Full Text] [Related]
20. A prediction model for early death in non-small cell lung cancer patients following curative-intent chemoradiotherapy.
Jochems A; El-Naqa I; Kessler M; Mayo CS; Jolly S; Matuszak M; Faivre-Finn C; Price G; Holloway L; Vinod S; Field M; Barakat MS; Thwaites D; de Ruysscher D; Dekker A; Lambin P
Acta Oncol; 2018 Feb; 57(2):226-230. PubMed ID: 29034756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]